Evidence map›Paper›PMID 36964442›Full record

GuidelineNeurocritical care2023

Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome.

Katharina M Busl, Herbert Fried, Susanne Muehlschlegel, Katja E Wartenberg, Venkatakrishna Rajajee, Sheila A Alexander, Claire J Creutzfeldt, Gabriel V Fontaine, Sara E Hocker, David Y Hwang and 9 more

Erratum issuedOpen access · hybridAbstract readGuidelineSystematic Review
In one paragraph

Guideline in Neurocritical care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Prognostic value of modified Erasmus Guillaiun Barre' syndrome outcome score (mEGOS) in an Italian cohort of patients: Challenges, insights and limitations.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Guillain-Barré syndrome.BJA education · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 18 institutions in 2 countries.

Katharina M BuslDepartments of Neurology and Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, USA.
Herbert FriedDepartment of Neurosurgery, Denver Health Medical Center, Denver, CO, USA.
Susanne MuehlschlegelDepartments of Neurology, Anesthesiology, and Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Katja E WartenbergDepartment of Neurology, University of Leipzig, Leipzig, Germany.
Venkatakrishna RajajeeDepartments of Neurology and Neurosurgery, University of Michigan, Ann Arbor, MI, USA.
Sheila A AlexanderSchool of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Claire J CreutzfeldtDepartment of Neurology, University of Washington, Seattle, WA, USA.
Gabriel V FontaineDepartments of Pharmacy and Neurosciences, Intermountain Health, Salt Lake City, UT, USA.
Sara E HockerDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
David Y HwangDepartment of Neurology, University of North Carolina, Chapel Hill, NC, USA.
Keri S KimDepartment of Pharmacy Practice, University of Illinois, Chicago, IL, USA.
Dominik MadzarDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Dea MahanesDepartments of Neurology and Neurosurgery, University of Virginia Health, Charlottesville, VA, USA.
Shraddha MainaliDepartment of Neurology, Virginia Commonwealth University, Richmond, VA, USA.
Juergen MeixensbergerDepartment of Neurosurgery, University of Leipzig, Leipzig, Germany.
Oliver W SakowitzDepartment of Neurosurgery, Neurosurgery Center Ludwigsburg-Heilbronn, Ludwigsburg, Germany.
Panayiotis N VarelasDepartment of Neurology, Albany Medical College, Albany, NY, USA.
Thomas WestermaierDepartment of Neurosurgery, University of Würzburg, Würzburg, Germany.
Christian WeimarInstitute of Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, Essen and BDH-Clinic Elzach, Essen, Germany. Christian.Weimar@uk-essen.de.
Leipzig University · DEAlbany Medical Center Hospital · USDenver Health Medical Center · USEssen University Hospital · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEIntermountain Healthcare · USKlinikum Ludwigsburg · DEMayo Clinic in Arizona · USUniversity of Florida · USUniversity of Illinois Chicago · USUniversity of Massachusetts Chan Medical School · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · USUniversity of Virginia · USUniversity of Washington · USUniversity of Würzburg · DEVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuillain-Barré syndrome (GBS) often carries a favorable prognosis. Of adult patients with GBS, 10-30% require mechanical ventilation during the acute phase of the disease. After the acute phase, the focus shifts to restoration of motor strength, ambulation, and neurological function, with variable speed and degree of recovery. The objective of these guidelines is to provide recommendations on the reliability of select clinical predictors that serve as the basis of neuroprognostication and provide guidance to clinicians counseling adult patients with GBS and/or their surrogates.

methodsA narrative systematic review was completed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Candidate predictors, including clinical variables and prediction models, were selected based on clinical relevance and presence of appropriate body of evidence. The Population/Intervention/Comparator/Outcome/Time frame/Setting (PICOTS) question was framed as follows: "When counseling patients or surrogates of critically ill patients with Guillain-Barré syndrome, should [predictor, with time of assessment if appropriate] be considered a reliable predictor of [outcome, with time frame of assessment]?" Additional full-text screening criteria were used to exclude small and lower quality studies. Following construction of an evidence profile and summary of findings, recommendations were based on four GRADE criteria: quality of evidence, balance of desirable and undesirable consequences, values and preferences, and resource use. In addition, good practice recommendations addressed essential principles of neuroprognostication that could not be framed in PICOTS format.

resultsEight candidate clinical variables and six prediction models were selected. A total of 45 articles met our eligibility criteria to guide recommendations. We recommend bulbar weakness (the degree of motor weakness at disease nadir) and the Erasmus GBS Respiratory Insufficiency Score as moderately reliable for prediction of the need for mechanical ventilation. The Erasmus GBS Outcome Score (EGOS) and modified EGOS were identified as moderately reliable predictors of independent ambulation at 3 months and beyond. Good practice recommendations include consideration of both acute and recovery phases of the disease during prognostication, discussion of the possible need for mechanical ventilation and enteral nutrition during counseling, and consideration of the complete clinical condition as opposed to a single variable during prognostication.

conclusionsThese guidelines provide recommendations on the reliability of predictors of the need for mechanical ventilation, poor functional outcome, and independent ambulation following GBS in the context of counseling patients and/or surrogates and suggest broad principles of neuroprognostication. Few predictors were considered moderately reliable based on the available body of evidence, and higher quality data are needed.

Indexed as

Guillain-Barre SyndromeRespiratory InsufficiencyAdultHumansPrognosisReproducibility of ResultsRespiration, ArtificialGuillain–Barré syndromeOutcomePolyradiculoneuropathyPrognosis

Identifiers

PMID36964442
PMCPMC10241707
OpenAlexW4360801677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.